133 related articles for article (PubMed ID: 35861395)
1. Autologous stem cell transplantation improves cardiopulmonary exercise testing outcomes in systemic sclerosis patients.
Gadioli LP; Costa-Pereira K; Dias JBE; Moraes DA; Crescêncio JC; Schwartzmann PV; Gallo-Júnior L; Schmidt A; Oliveira MC
Rheumatology (Oxford); 2023 Feb; 62(SI):SI101-SI106. PubMed ID: 35861395
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Stem Cell Transplantation Improves Functional Outcomes of Systemic Sclerosis Patients.
Costa-Pereira KR; Guimarães AL; Moraes DA; Dias JBE; Garcia JT; de Oliveira-Cardoso EA; Zombrilli A; Leopoldo V; Costa TM; Simões BP; Oliveira MC
J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S131-S138. PubMed ID: 31397762
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.
Puyade M; Maltez N; Lansiaux P; Pugnet G; Roblot P; Colmegna I; Hudson M; Farge D
Rheumatology (Oxford); 2020 Apr; 59(4):779-789. PubMed ID: 31504944
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.
Keret S; Henig I; Zuckerman T; Kaly L; Shouval A; Awisat A; Rosner I; Rozenbaum M; Boulman N; Dortort Lazar A; Molad Y; Sabbah F; Naffaa ME; Hardak E; Slobodin G; Rimar D
Rheumatology (Oxford); 2024 May; 63(6):1534-1538. PubMed ID: 37672021
[TBL] [Abstract][Full Text] [Related]
6. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
[TBL] [Abstract][Full Text] [Related]
7. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
[TBL] [Abstract][Full Text] [Related]
8. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.
Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A
Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527
[TBL] [Abstract][Full Text] [Related]
9. Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis.
Del Papa N; Onida F; Zaccara E; Saporiti G; Maglione W; Tagliaferri E; Andracco R; Vincenti D; Montemurro T; Mircoli L; Vitali C; Cortelezzi A
Bone Marrow Transplant; 2017 Jan; 52(1):53-58. PubMed ID: 27548467
[TBL] [Abstract][Full Text] [Related]
10. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
11. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.
Pecher AC; Klein R; Koetter I; Wagner M; Vogel W; Wirths S; Lengerke C; Henes JC
Arthritis Res Ther; 2024 Mar; 26(1):75. PubMed ID: 38509633
[TBL] [Abstract][Full Text] [Related]
12. Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis.
Boukouaci W; Lansiaux P; Lambert NC; Picard C; Clave E; Cras A; Marjanovic Z; Farge D; Tamouza R
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806227
[TBL] [Abstract][Full Text] [Related]
13. [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology].
Alexander T; Henes J; Distler JHW; Schmalzing M; Blank N; Kötter I; Hiepe F
Z Rheumatol; 2020 Jun; 79(5):429-436. PubMed ID: 32322977
[TBL] [Abstract][Full Text] [Related]
14. Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients.
Strunz PP; Froehlich M; Gernert M; Schwaneck EC; Fleischer A; Pecher AC; Tony HP; Henes JC; Schmalzing M
Front Immunol; 2021; 12():723349. PubMed ID: 34539659
[TBL] [Abstract][Full Text] [Related]
15. Automatic Quantitative Computed Tomography Evaluation of the Lungs in Patients With Systemic Sclerosis Treated With Autologous Stem Cell Transplantation.
Wada DT; de Almeida FA; de Moraes DA; Dias JBE; Baddini-Martinez J; Oliveira MC; Koenigkam-Santos M
J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S158-S164. PubMed ID: 31868835
[TBL] [Abstract][Full Text] [Related]
16. Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation.
Dulko AJ; Butrimiene I; Cypiene A; Peceliunas V; Petroska D; Stankeviciene E; Rugiene R
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541223
[TBL] [Abstract][Full Text] [Related]
17. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients.
Zanin-Silva DC; Santana-Gonçalves M; Kawashima-Vasconcelos MY; Lima-Júnior JR; Dias JBE; Moraes DA; Covas DT; Malmegrim KCR; Ramalho L; Oliveira MC
Arthritis Res Ther; 2022 Apr; 24(1):95. PubMed ID: 35488348
[TBL] [Abstract][Full Text] [Related]
18. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
[TBL] [Abstract][Full Text] [Related]
19. Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation.
Pugnet G; Petermann A; Collot S; Otal P; Lansiaux P; Ait Abdallah N; Lorillon G; Resche-Rigon M; Borel C; Marjanovic Z; Farge D;
Rheumatology (Oxford); 2023 Feb; 62(SI):SI32-SI42. PubMed ID: 35686921
[TBL] [Abstract][Full Text] [Related]
20. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.
Arruda LCM; Malmegrim KCR; Lima-Júnior JR; Clave E; Dias JBE; Moraes DA; Douay C; Fournier I; Moins-Teisserenc H; Alberdi AJ; Covas DT; Simões BP; Lansiaux P; Toubert A; Oliveira MC
Blood Adv; 2018 Jan; 2(2):126-141. PubMed ID: 29365321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]